David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.43% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.31% |
| 5 | Healthcare | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Sana Biotechnology
SANA
$1.18B
| $1.99M | ﹤0.01% |
240,549
-47,552
| -17% | -$384K |
|
3152
CALL
Marvell Technology
MRVL
$195B
| $1.99M | ﹤0.01% |
27,700
-131,400
| -83% | -$9.47M |
|
|
CREC
3153
DELISTED
Crescera Capital Acquisition Corp Class A Ordinary Shares
CREC
| $1.99M | ﹤0.01% |
+200,000
| New | +$1.97M |
|
3154
PUT
Brinker International
EAT
$9.87B
| $1.98M | ﹤0.01% |
52,000
+2,000
| +4% | +$74.8K |
|
|
HMA
3155
DELISTED
Heartland Media Acquisition Corp.
HMA
| $1.98M | ﹤0.01% |
+200,000
| New | +$1.98M |
|
|
TRTN
3156
DELISTED
Triton International Limited
TRTN
| $1.98M | ﹤0.01% |
+28,206
| New | +$1.82M |
|
3157
Cullen/Frost Bankers
CFR
$10B
| $1.98M | ﹤0.01% |
14,290
-9,034
| -39% | -$1.26M |
|
3158
Prudential Financial
PRU
$41.3B
| $1.98M | ﹤0.01% |
16,733
-67,283
| -80% | -$7.65M |
|
3159
Cardio Diagnostics
CDIO
$5.48M
| $1.98M | ﹤0.01% |
+6,668
| New | +$1.97M |
|
3160
Polaris
PII
$3.63B
| $1.97M | ﹤0.01% |
18,693
-15,203
| -45% | -$1.73M |
|
|
IVC
3161
DELISTED
Invacare Corporation
IVC
| $1.97M | ﹤0.01% |
1,394,763
-211,522
| -13% | -$452K |
|
3162
EyePoint Inc
EYPT
$386M
| $1.97M | ﹤0.01% |
161,719
-116,953
| -42% | -$1.28M |
|
3163
Petco
WOOF
$771M
| $1.96M | ﹤0.01% |
+100,363
| New | +$1.88M |
|
|
MRO
3164
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.96M | ﹤0.01% |
78,000
+24,600
| +46% | +$528K |
|
3165
PUT
Applovin
APP
$106B
| $1.96M | ﹤0.01% |
+35,500
| New | +$2.26M |
|
3166
CALL
Nokia
NOK
$57.2B
| $1.95M | ﹤0.01% |
357,800
-100
| -0% | -$554 |
|
3167
V2X
VVX
$2.44B
| $1.95M | ﹤0.01% |
54,449
-16,971
| -24% | -$725K |
|
|
ZIMV
3168
DELISTED
ZimVie
ZIMV
| $1.95M | ﹤0.01% |
+85,434
| New | +$2.01M |
|
|
HGEN
3169
DELISTED
HUMANIGEN, INC.
HGEN
| $1.95M | ﹤0.01% |
647,291
+194,208
| +43% | +$520K |
|
|
AUD
3170
DELISTED
Audacy, Inc.
AUD
| $1.95M | ﹤0.01% |
673,138
+123,435
| +22% | +$326K |
|
|
BAND
3171
PUT
Bandwidth Inc
BAND
$1.58B
| $1.94M | ﹤0.01% |
60,000
-40,900
| -41% | -$1.96M |
|
3172
Omega Healthcare
OHI
$13.9B
| $1.94M | ﹤0.01% |
62,359
-251,548
| -80% | -$7.42M |
|
|
THR
3173
DELISTED
Thermon Group Holdings
THR
| $1.94M | ﹤0.01% |
119,935
-58,411
| -33% | -$1.02M |
|
3174
CALL
Kadant
KAI
$3.57B
| $1.94M | ﹤0.01% |
10,000
| – | – |
|
3175
CALL
Fate Therapeutics
FATE
$291M
| $1.94M | ﹤0.01% |
+50,000
| New | +$1.94M |
|
Similar funds
David Shaw's Q1 2022 Portfolio in Review
As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
David Shaw withdrew a net $10.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.
- David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
- David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- David Shaw opened 934 new positions and closed 805 in Q1 2022.
- David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.